CEO in Lytix Biopharma, Øystein Rekdal, will be giving an oral presentation at this years' ESMO congress.

His presentation, 'Use of oncolytic peptides to overcome tumour heterogeneity', will be helt on March 1st 2021, 4:30PM, under the session 'Where next with oncolytics'.

Rekdal will also join the live Q&A panel at 5PM.

Read more about the congress